Dana Pizzuti, Chief Med and Development Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 5,000 shares at $39.07 ($195K) on 2025-02-03, disclosed to the SEC on 2025-02-05.
Scheduled sale ($195k) by Chief Med and Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CRNX | SELL | 2025-10-03 | $209K | — | Filing → |
| CRNX | SELL | 2025-09-04 | $161K | — | Filing → |
| CRNX | SELL | 2025-08-26 | $913K | — | Filing → |